Shockwave Dose for Adhesive Capsulitis

NCT07325318 | Completed

• 1 other identifier: 108-124-E
• Study Type: interventional
• Target: 48
• Locations: 1 country
• Sites: 1

Brief Summary

The investigators evaluated the therapeutic efficacy of different shockwave dosages for adhesive capsulitis and further examined the temporal effects and subgroup responses based on baseline range of motion

Conditions

Adhesive Capsulitis, Shoulder

Keywords

Adhesive capsulitis; Range of motion; Extracorporeal shockwave therapy

Outcome Measures

Primary Outcomes (1)

• We assessed changes in shoulder range of motion using a standard goniometer before and after treatment with varying shockwave dosages

  In patients receiving different doses of extracorporeal shockwave therapy for adhesive capsulitis, we assessed changes in shoulder range of motion before and after treatment using a standard goniometer. We will assess forward flexion, abduction, external rotation, and internal rotation. The better the range of motion, the better the treatment outcome.

  Before treatment, immediately after treatment, and at 1, 2, 4, 8, and 12 weeks post-treatment

Secondary Outcomes (2)

• We assessed changes in shoulder functional outcomes using the Constant-Murley questionnaire before and after treatment with varying shockwave dosages

  before treatment and 12 weeks posttreatment

• The impact of changes over time before and after shockwave therapy on joint angle improvement

  immediately after treatment and 1, 2, 4, 8, and 12 weeks posttreatment

Study Arms (2)

extracoporeal sockwave therapy basic dose

EXPERIMENTAL

3,000 pulses of shockwave per session as the basic treatment

Device: focused extracoporeal sockwave

extracoporeal shockwave therapy high dose

EXPERIMENTAL

6,000 pulses of shockwave per session as the high dose treatment

Device: focused extracoporeal sockwave

Interventions

focused extracoporeal sockwave DEVICE

Focused ESWT energy was initiated at level 5 (0.034 mJ/mm²) with a 4-Hz frequency and subsequently adjusted based on patient tolerance. After the application of coupling gel, different pulses were applied one fingerbreadth inferior to the anterior acromion, lateral to the acromion, and posterior to the acromion.

extracoporeal shockwave therapy high dose; extracoporeal sockwave therapy basic dose

Eligibility Criteria

• Age: 20 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• patient age ≥ 20 years
• first episode of adhesive capsulitis
• persistent shoulder pain with restricted motion for ≥ 3 months
• prior management limited to analgesic medications
• active abduction in the scapular plane ≤ 135°

You may not qualify if:

• shoulder or cervical pathology
• history of shoulder fracture, infection, or tumor
• previous shoulder surgery
• pacemaker presence
• pregnancy
• coagulopathy
• inability to complete follow-up assessments

Sponsors & Collaborators

• National Taiwan University Hospital Hsin-Chu Branch: lead

Study Sites (1)

National Taiwan University Hospital Hsin-Chu Branch

Hsinchu, 300195, Taiwan

Location

Related Publications (5)

• Wang CJ, Huang CC, Yip HK, Yang YJ. Dosage effects of extracorporeal shockwave therapy in early hip necrosis. Int J Surg. 2016 Nov;35:179-186. doi: 10.1016/j.ijsu.2016.09.013. Epub 2016 Sep 21.

  PMID: 27664561 BACKGROUND

• El Naggar TEDM, Maaty AIE, Mohamed AE. Effectiveness of radial extracorporeal shock-wave therapy versus ultrasound-guided low-dose intra-articular steroid injection in improving shoulder pain, function, and range of motion in diabetic patients with shoulder adhesive capsulitis. J Shoulder Elbow Surg. 2020 Jul;29(7):1300-1309. doi: 10.1016/j.jse.2020.03.005.

  PMID: 32553435 BACKGROUND

• Gerdesmeyer L, Wagenpfeil S, Haake M, Maier M, Loew M, Wortler K, Lampe R, Seil R, Handle G, Gassel S, Rompe JD. Extracorporeal shock wave therapy for the treatment of chronic calcifying tendonitis of the rotator cuff: a randomized controlled trial. JAMA. 2003 Nov 19;290(19):2573-80. doi: 10.1001/jama.290.19.2573.

  PMID: 14625334 BACKGROUND

• Yao G, Chen J, Duan Y, Chen X. Efficacy of Extracorporeal Shock Wave Therapy for Lateral Epicondylitis: A Systematic Review and Meta-Analysis. Biomed Res Int. 2020 Mar 18;2020:2064781. doi: 10.1155/2020/2064781. eCollection 2020.

  PMID: 32309425 BACKGROUND

• Walker-Bone K, Palmer KT, Reading I, Coggon D, Cooper C. Prevalence and impact of musculoskeletal disorders of the upper limb in the general population. Arthritis Rheum. 2004 Aug 15;51(4):642-51. doi: 10.1002/art.20535.

  PMID: 15334439 BACKGROUND

Related Links

• The website describes the shockwave device used in the study as well as the underlying treatment principles.

MeSH Terms

Conditions

Bursitis

Condition Hierarchy (Ancestors)

Joint Diseases; Musculoskeletal Diseases

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: OUTCOMES ASSESSOR
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Model Details: two different shockwave doses are performed to treat adhesive capsulitis

Study Record Dates

• First Submitted: November 24, 2025
• First Posted: January 8, 2026
• Study Start: January 1, 2021
• Primary Completion: December 31, 2021
• Study Completion: December 31, 2021
• Last Updated: January 8, 2026

Record last verified: 2026-01

Data Sharing

• IPD Sharing: Will not share

Locations

TW (1)